BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33148660)

  • 1. ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth.
    Wang Y; Luo M; Chen Y; Wang Y; Zhang B; Ren Z; Bao L; Wang Y; Wang JE; Fu YX; Luo W; Wang Y
    Cancer Res; 2021 Jan; 81(1):174-186. PubMed ID: 33148660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer.
    Qiu F; Jin Y; Pu J; Huang Y; Hou J; Zhao X; Lu Y
    Exp Cell Res; 2021 Oct; 407(2):112807. PubMed ID: 34487730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk.
    Thounaojam MC; Dudimah DF; Pellom ST; Uzhachenko RV; Carbone DP; Dikov MM; Shanker A
    Oncotarget; 2015 Oct; 6(32):32439-55. PubMed ID: 26431276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.
    Basu M; Sengupta I; Khan MW; Srivastava DK; Chakrabarti P; Roy S; Das C
    Biochem J; 2017 May; 474(11):1919-1934. PubMed ID: 28432260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization.
    Mukherjee S; Adhikary S; Gadad SS; Mondal P; Sen S; Choudhari R; Singh V; Adhikari S; Mandal P; Chaudhuri S; Sengupta A; Lakshmanaswamy R; Chakrabarti P; Roy S; Das C
    Cell Death Dis; 2020 Dec; 11(12):1073. PubMed ID: 33323928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
    Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.
    Choi H; Kwon J; Cho MS; Sun Y; Zheng X; Wang J; Bouker KB; Casey JL; Atkins MB; Toretsky J; Han C
    Cancer Res; 2021 Jul; 81(13):3607-3620. PubMed ID: 33941613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
    Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
    J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer.
    Huang D; Chen X; Zeng X; Lao L; Li J; Xing Y; Lu Y; Ouyang Q; Chen J; Yang L; Su F; Yao H; Liu Q; Su S; Song E
    Nat Immunol; 2021 Jul; 22(7):865-879. PubMed ID: 34140678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.
    Gómez-Aleza C; Nguyen B; Yoldi G; Ciscar M; Barranco A; Hernández-Jiménez E; Maetens M; Salgado R; Zafeiroglou M; Pellegrini P; Venet D; Garaud S; Trinidad EM; Benítez S; Vuylsteke P; Polastro L; Wildiers H; Simon P; Lindeman G; Larsimont D; Van den Eynden G; Velghe C; Rothé F; Willard-Gallo K; Michiels S; Muñoz P; Walzer T; Planelles L; Penninger J; Azim HA; Loi S; Piccart M; Sotiriou C; González-Suárez E
    Nat Commun; 2020 Dec; 11(1):6335. PubMed ID: 33303745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity.
    Markosyan N; Chen EP; Evans RA; Ndong V; Vonderheide RH; Smyth EM
    Breast Cancer Res; 2013; 15(5):R75. PubMed ID: 24004819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity.
    Grisaru-Tal S; Dulberg S; Beck L; Zhang C; Itan M; Hediyeh-Zadeh S; Caldwell J; Rozenberg P; Dolitzky A; Avlas S; Hazut I; Gordon Y; Shani O; Tsuriel S; Gerlic M; Erez N; Jacquelot N; Belz GT; Rothenberg ME; Davis MJ; Yu H; Geiger T; Madi A; Munitz A
    Cancer Res; 2021 Nov; 81(21):5555-5571. PubMed ID: 34429328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.
    Shi F; Su J; Wang J; Liu Z; Wang T
    Mol Cell Biochem; 2021 Feb; 476(2):1015-1024. PubMed ID: 33141310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.
    Huang Y; Ma C; Zhang Q; Ye J; Wang F; Zhang Y; Hunborg P; Varvares MA; Hoft DF; Hsueh EC; Peng G
    Oncotarget; 2015 Jul; 6(19):17462-78. PubMed ID: 25968569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
    Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
    Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptotanshinone induces inhibition of breast tumor growth by cytotoxic CD4+ T cells through the JAK2/STAT4/ perforin pathway.
    Zhou J; Xu XZ; Hu YR; Hu AR; Zhu CL; Gao GS
    Asian Pac J Cancer Prev; 2014; 15(6):2439-45. PubMed ID: 24761844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role of tumor suppressor ZMYND8 in inducing differentiation of breast cancer cells through its dual-histone binding function.
    Mukherjee S; Sen S; Adhikary S; Sengupta A; Mandal P; Dasgupta D; Chakrabarti P; Roy S; DAS C
    J Biosci; 2020; 45():. PubMed ID: 31965980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.